These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 22630053

  • 1. Immune regulatory gene polymorphisms as predisposing risk factors for the development of factor VIII inhibitors in Indian severe haemophilia A patients.
    Pinto P, Ghosh K, Shetty S.
    Haemophilia; 2012 Sep; 18(5):794-7. PubMed ID: 22630053
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A.
    Bafunno V, Santacroce R, Chetta M, D'Andrea G, Pisanelli D, Sessa F, Trotta T, Tagariello G, Peyvandi F, Margaglione M.
    Haemophilia; 2010 May; 16(3):469-73. PubMed ID: 20015215
    [Abstract] [Full Text] [Related]

  • 3. Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A.
    Chaves D, Belisário A, Castro G, Santoro M, Rodrigues C.
    Int J Immunogenet; 2010 Apr; 37(2):79-82. PubMed ID: 20082647
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immune system polymorphisms and factor VIII inhibitor formation in Brazilian haemophilia A severe patients.
    Agostini D, Rosset C, Botton MR, Kappel DB, Vieira IA, Gorziza RP, Salzano FM, Bandinelli E.
    Haemophilia; 2012 Nov; 18(6):e416-8. PubMed ID: 22970761
    [No Abstract] [Full Text] [Related]

  • 6. Genetic variants of TNFα, IL10, IL1β, CTLA4 and TGFβ1 modulate the indices of alcohol-induced liver injury in East Indian population.
    Roy N, Mukhopadhyay I, Das K, Pandit P, Majumder PP, Santra A, Datta S, Banerjee S, Chowdhury A.
    Gene; 2012 Nov 01; 509(1):178-88. PubMed ID: 22902304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.
    Coppola A, Santoro C, Tagliaferri A, Franchini M, DI Minno G.
    Haemophilia; 2010 Jan 01; 16 Suppl 1():13-9. PubMed ID: 20059564
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The correlation between gene mutations and inhibitor development in patients with haemophilia A in southern Iran.
    Haghpanah S, Sahraiian M, Afrasiabi A, Enayati S, Peyvandi F, Karimi M.
    Haemophilia; 2011 Sep 01; 17(5):820-1. PubMed ID: 21371201
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.
    Ivaskevicius V, Goldmann G, Horneff S, Marquardt N, Klein C, Albert T, Zeitler H, Oldenburg J.
    Hamostaseologie; 2014 Sep 01; 34 Suppl 1():S9-12. PubMed ID: 25382774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characteristics of inhibitors in mild/moderate haemophilia A.
    Peerlinck K, Jacquemin M.
    Haemophilia; 2006 Dec 01; 12 Suppl 6():43-7. PubMed ID: 17123393
    [Abstract] [Full Text] [Related]

  • 18. The need for previously untreated patient population studies in understanding the development of factor VIII inhibitors.
    Gomperts ED.
    Haemophilia; 2006 Nov 01; 12(6):573-8. PubMed ID: 17083506
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.